FOXA2 mRNA expression is associated with relapse in patients with Triple-Negative/Basal-like breast carcinoma

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Dennis J. Slamon, Brian Leyland‐Jones, Steven Shak et al. · New England Journal of Medicine · 2001 · 11.5K citations · Full text

Medicine, Oncology, Pharmacology +10

pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

C.W. Elston, Ian O. Ellis · Histopathology · 1991 · 6.2K citations

Medicine, Oncology, Pathology +17

Repeated observation of breast tumor subtypes in independent gene expression data sets

Thérese Sørlie, Robert Tibshirani, Joel S. Parker et al. · Proceedings of the National Academy of Sciences · 2003 · 5.4K citations · Full text

Medicine, Molecular Biology, Oncology +17

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Richard M. Neve, Koei Chin, Jane Fridlyand et al. · Cancer Cell · 2006 · 3.2K citations · Full text

Medicine, Cell Biology, Oncology +14

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess et al. · Journal of Clinical Oncology · 2008 · 2.9K citations · Full text

Medicine, Oncology, Breast Oncology +16